| LII |
Report |
Q2 2026 Revenue |
BEAT |
pred ~$1.585B vs. cons ~$1.56B |
MEDIUM |
| LII |
Report |
Q2 2026 Adjusted EPS |
BEAT |
pred ~$7.78 vs. cons ~$7.62 |
MEDIUM |
| LII |
Report |
HCS Segment Margin (Q2) |
BEAT |
pred ~24.0% vs. cons ~23.2% |
MEDIUM |
| LII |
Guide |
FY2026 Adjusted EPS Guidance |
BETTER |
guide ~$24.00-$25.00 (narrowed to upper half) vs. cons ~$24.30 midpoint (FY2026) |
MEDIUM |
| LII |
Guide |
FY2026 Revenue Growth Guidance |
UNCHANGED |
guide ~8% vs. cons ~8% (FY2026) |
MEDIUM |
| LII |
Guide |
FY2026 Cost Inflation Assumption |
BETTER |
guide ~3-3.5% (down from ~5% at Q1 on tariff relief) vs. cons ~5% prior assumption (FY2026) |
LOW |
| LII |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.8% |
— |
MEDIUM |
| LII |
Return |
5-day cumulative residual |
+0.4% (FADE) |
Beat plus tariff-driven cost relief is largely already known/priced (June 232 tariff cut, Carrier's Q2 beat-and-raise the day before), so the initial pop reflects confirmation rather than new information. With FY guidance reaffirmed rather than raised despite the favorable tariff shift, sell-side models likely already embed most of the good news; residual H2 uncertainty (new-construction drag, elevated non-tariff commodity costs, litigation overhang) plus a stock that ran up into the print (~5% pullback from highs but still near 52-week highs) sets up partial giveback over the week as short-term buyers take profits and estimate revisions normalize rather than extend. |
LOW |